(Q34326110)

English

Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis (English)

1 reference

Europe PubMed Central

1 August 2017

author name string

Sambasiva P Rao

1

1 reference

Europe PubMed Central

1 August 2017

Jose Sancho

2

1 reference

Europe PubMed Central

1 August 2017

Juanita Campos-Rivera

3

1 reference

Europe PubMed Central

1 August 2017

Paula M Boutin

4

1 reference

Europe PubMed Central

1 August 2017

Peter B Severy

5

1 reference

Europe PubMed Central

1 August 2017

Timothy Weeden

6

1 reference

Europe PubMed Central

1 August 2017

Srinivas Shankara

7

1 reference

Europe PubMed Central

1 August 2017

Bruce L Roberts

8

1 reference

Europe PubMed Central

1 August 2017

Johanne M Kaplan

9

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

25 June 2012

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

7

1 reference

Europe PubMed Central

1 August 2017

6

1 reference

Europe PubMed Central

1 August 2017

e39416

1 reference

Europe PubMed Central

1 August 2017

copyright license

Creative Commons Attribution 4.0 International

25 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Effect of alemtuzumab on neoplastic B cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

The CD52 antigen and development of the CAMPATH antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

CD52 (CAMPATH1).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Pharmacokinetics of CAMPATH-1H: assay development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Heterogeneity of human peripheral blood monocyte subsets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Terminology and nomenclature for standardization in quantitative fluorescence cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Control of the complement system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Recognition of CD52 allelic gene products by CAMPATH-1H antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Reshaping human antibodies for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

6 July 2018

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382607

27 October 2018

Effect of Campath-1H antibody on human hematopoietic progenitors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CAMPATH-1 antigen (CDw52)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glycosylphosphatidylinositol-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD27: a memory B-cell marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement

1 reference

https://pubmed.ncbi.nlm.nih.gov/22761788

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0039416

1 reference

Europe PubMed Central

1 August 2017

2012PLoSO...739416R

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34326110&oldid=1867123898"